Aridis Pharmaceuticals Ownership 2024 | Who Owns Aridis Pharmaceuticals Now?


OverviewChart

Institutional Ownership

0.00%

Insider Ownership

18.05%

Retail Ownership

81.95%

Institutional Holders

1.00

Aridis Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BARTLETT & CO. WEALTH MANAGEMENT LLC----150-100.00%-Mar 31, 2024

Aridis Pharmaceuticals's largest institutional shareholder is BARTLETT & CO. WEALTH MANAGEMENT LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BARTLETT & CO. WEALTH MANAGEMENT LLC----150-100.00%-Mar 31, 2024

The largest Aridis Pharmaceuticals shareholder by % of total assets is BARTLETT & CO. WEALTH MANAGEMENT LLC. The company owns 0.00 shares of Aridis Pharmaceuticals (ARDS), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BARTLETT & CO. WEALTH MANAGEMENT LLC----150-100.00%-Mar 31, 2024

As of Mar 31 2024, Aridis Pharmaceuticals's largest institutional buyer is BARTLETT & CO. WEALTH MANAGEMENT LLC. The company purchased -0.15K stocks of ARDS, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BARTLETT & CO. WEALTH MANAGEMENT LLC----150-100.00%-Mar 31, 2024

As of Mar 31 2024, Aridis Pharmaceuticals's biggest institutional seller is BARTLETT & CO. WEALTH MANAGEMENT LLC. The company sold -0.15K shares of ARDS, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BARTLETT & CO. WEALTH MANAGEMENT LLC----150-100.00%-Mar 31, 2024

Aridis Pharmaceuticals's largest sold out institutional shareholder by shares sold is BARTLETT & CO. WEALTH MANAGEMENT LLC, sold -0.15K shares, valued at -, as of undefined.

Aridis Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Starboard Investment Trust0.77%446,588--Feb 29, 2024
PERRITT FUNDS INC0.20%24,000--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%5,453--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%134,779--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%251,731--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%365--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%2,078--Jan 31, 2024
EQ ADVISORS TRUST0.00%1,851--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%495--Mar 31, 2024

Aridis Pharmaceuticals's largest mutual fund holder by % of total assets is "Starboard Investment Trust", owning 446.59K shares, compromising 0.77% of its total assets.

Aridis Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Dec, 231-
30 Sep, 231-94.44%
30 Jun, 2318-10.00%
31 Mar, 232025.00%
31 Dec, 2216-
30 Sep, 2216-15.79%
30 Jun, 2219-5.00%
31 Mar, 2220-
31 Dec, 212017.65%
30 Sep, 211730.77%
30 Jun, 211318.18%
31 Mar, 2111-
31 Dec, 201157.14%
30 Sep, 20716.67%
30 Jun, 206-
31 Mar, 206-
31 Dec, 196-14.29%
30 Sep, 19740.00%
30 Jun, 19525.00%
31 Mar, 194-
31 Dec, 184-33.33%
30 Sep, 186-

As of 31 Dec 23, 1 institutions are holding Aridis Pharmaceuticals's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Dec, 23150-98.93%
30 Sep, 2314,077-98.81%
30 Jun, 231,187,583-66.36%
31 Mar, 233,530,5646.70%
31 Dec, 223,308,903143.34%
30 Sep, 221,359,8114.44%
30 Jun, 221,302,059-3.20%
31 Mar, 221,345,0677.65%
31 Dec, 211,249,474-37.26%
30 Sep, 211,991,44084.89%
30 Jun, 211,077,0716.29%
31 Mar, 211,013,35236.71%
31 Dec, 20741,254305.86%
30 Sep, 20182,63670.57%
30 Jun, 20107,07212.27%
31 Mar, 2095,3681.94%
31 Dec, 1993,555-15.90%
30 Sep, 19111,245136.79%
30 Jun, 1946,980-19.53%
31 Mar, 1958,379299.97%
31 Dec, 1814,596-73.78%
30 Sep, 1855,667-

Aridis Pharmaceuticals (ARDS) has 150.00 shares outstanding as of 31 Dec 23, down -98.93% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Dec, 230.00%26.41%
30 Sep, 230.04%0.26%
30 Jun, 233.90%2.90%
31 Mar, 2311.61%9.81%
31 Dec, 2210.88%18.44%
30 Sep, 227.68%14.20%
30 Jun, 227.36%12.74%
31 Mar, 227.60%10.23%
31 Dec, 218.62%3.37%
30 Sep, 2115.99%17.39%
30 Jun, 219.59%9.77%
31 Mar, 219.91%15.16%
31 Dec, 208.08%192.99%
30 Sep, 202.05%142.15%
30 Jun, 201.20%104.96%
31 Mar, 201.07%97.07%
31 Dec, 191.05%64.10%
30 Sep, 191.28%381.04%
30 Jun, 190.58%111.72%
31 Mar, 190.72%2220.54%
31 Dec, 180.18%38.18%
30 Sep, 180.69%-

As of 31 Dec 23, Aridis Pharmaceuticals is held by 0.00% institutional shareholders, representing a 26.41% growth compared to 30 Sep 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Dec, 231-
30 Sep, 23--100.00%
30 Jun, 237-22.22%
31 Mar, 23928.57%
31 Dec, 227-
30 Sep, 227-12.50%
30 Jun, 228-11.11%
31 Mar, 229-30.77%
31 Dec, 211318.18%
30 Sep, 211122.22%
30 Jun, 219-
31 Mar, 21912.50%
31 Dec, 208100.00%
30 Sep, 204-
30 Jun, 20433.33%
31 Mar, 20350.00%
31 Dec, 192-50.00%
30 Sep, 19433.33%
30 Jun, 193200.00%
31 Mar, 191-
31 Dec, 181-83.33%
30 Sep, 186-

1 institutional shareholders have increased their position in ARDS stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Dec, 23--
30 Sep, 23--100.00%
30 Jun, 232-50.00%
31 Mar, 234-
31 Dec, 224-
30 Sep, 22433.33%
30 Jun, 223-25.00%
31 Mar, 224-
31 Dec, 21--100.00%
30 Sep, 211-50.00%
30 Jun, 212100.00%
31 Mar, 211-
31 Dec, 201-50.00%
30 Sep, 202-
30 Jun, 20--100.00%
31 Mar, 202-33.33%
31 Dec, 193200.00%
30 Sep, 191-
30 Jun, 191-50.00%
31 Mar, 192-
31 Dec, 182-
30 Sep, 18--

- institutional shareholders have reduced their position in ARDS stock as of 31 Dec 23 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Dec, 231-150-98.93%0.00%26.41%1---
30 Sep, 231-94.44%14,077-98.81%0.04%0.26%--100.00%--100.00%
30 Jun, 2318-10.00%1,187,583-66.36%3.90%2.90%7-22.22%2-50.00%
31 Mar, 232025.00%3,530,5646.70%11.61%9.81%928.57%4-
31 Dec, 2216-3,308,903143.34%10.88%18.44%7-4-
30 Sep, 2216-15.79%1,359,8114.44%7.68%14.20%7-12.50%433.33%
30 Jun, 2219-5.00%1,302,059-3.20%7.36%12.74%8-11.11%3-25.00%
31 Mar, 2220-1,345,0677.65%7.60%10.23%9-30.77%4-
31 Dec, 212017.65%1,249,474-37.26%8.62%3.37%1318.18%--100.00%
30 Sep, 211730.77%1,991,44084.89%15.99%17.39%1122.22%1-50.00%
30 Jun, 211318.18%1,077,0716.29%9.59%9.77%9-2100.00%
31 Mar, 2111-1,013,35236.71%9.91%15.16%912.50%1-
31 Dec, 201157.14%741,254305.86%8.08%192.99%8100.00%1-50.00%
30 Sep, 20716.67%182,63670.57%2.05%142.15%4-2-
30 Jun, 206-107,07212.27%1.20%104.96%433.33%--100.00%
31 Mar, 206-95,3681.94%1.07%97.07%350.00%2-33.33%
31 Dec, 196-14.29%93,555-15.90%1.05%64.10%2-50.00%3200.00%
30 Sep, 19740.00%111,245136.79%1.28%381.04%433.33%1-
30 Jun, 19525.00%46,980-19.53%0.58%111.72%3200.00%1-50.00%
31 Mar, 194-58,379299.97%0.72%2220.54%1-2-
31 Dec, 184-33.33%14,596-73.78%0.18%38.18%1-83.33%2-
30 Sep, 186-55,667-0.69%-6---

Aridis Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 28, 2024Patzer Ericdirector-P-PurchaseBuy714,286$0.07$50.00K884,600
Jun 28, 2024Truong Vudirector, officer CEOP-PurchaseBuy714,286$0.07$50.00K1,378,639

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 28, 2024Patzer Ericdirector-P-PurchaseBuy714,286$0.07$50.00K884,600
Jun 28, 2024Truong Vudirector, officer CEOP-PurchaseBuy714,286$0.07$50.00K1,378,639

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 15, 2023Patzer Ericdirector, officer Executive ChairmanM-ExemptSell12,000--12,000
Jun 15, 2023HAMILTON JOHN Fdirector-M-ExemptSell5,000--5,000
Jun 15, 2023Truong Vudirector, officer CEO and DirectorM-ExemptSell15,000--15,000

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 28, 2024Windham-Bannister Susan Richardsdirector-A-AwardBuy200,000$0.06$12.60K261,000
Jun 28, 2024HAMILTON JOHN Fdirector-A-AwardBuy200,000$0.06$12.60K269,040
Jun 28, 2024Jafri Hasanofficer Chief Medical OfficerA-AwardBuy250,000$0.06$15.75K382,495
Jun 28, 2024Patzer Ericdirector-P-PurchaseBuy714,286$0.07$50.00K884,600
Jun 28, 2024Truong Vudirector, officer CEOP-PurchaseBuy714,286$0.07$50.00K1,378,639
Sep 19, 2023HAMILTON JOHN Fdirector-A-AwardBuy15,000$0.08$1.20K91,540
Sep 19, 2023Windham-Bannister Susan Richardsdirector-A-AwardBuy15,000$0.08$1.20K73,500
Sep 19, 2023Patzer Ericdirector, officer Executive ChairmanA-AwardBuy15,000$0.08$1.20K161,862
Sep 19, 2023Truong Vudirector, officer CEO and DirectorA-AwardBuy30,000$0.08$2.40K817,750
Sep 19, 2023Jafri Hasanofficer Chief Medical OfficerA-AwardBuy20,000$0.08$1.60K175,000
Jun 15, 2023Patzer Ericdirector, officer Executive ChairmanM-ExemptBuy12,000--714,132
Jun 15, 2023Patzer Ericdirector, officer Executive ChairmanA-AwardBuy30,000$0.16$4.80K146,862
Jun 15, 2023Patzer Ericdirector, officer Executive ChairmanM-ExemptSell12,000--12,000
Jun 15, 2023HAMILTON JOHN Fdirector-A-AwardBuy15,000$0.16$2.40K76,540
Jun 15, 2023HAMILTON JOHN Fdirector-M-ExemptBuy5,000--5,000
Jun 15, 2023HAMILTON JOHN Fdirector-M-ExemptSell5,000--5,000
Jun 15, 2023Truong Vudirector, officer CEO and DirectorA-AwardBuy100,000$0.16$16.00K787,750
Jun 15, 2023Truong Vudirector, officer CEO and DirectorM-ExemptBuy15,000--752,353
Jun 15, 2023Truong Vudirector, officer CEO and DirectorM-ExemptSell15,000--15,000
Jun 15, 2023Windham-Bannister Susan Richardsdirector-A-AwardBuy15,000$0.16$2.40K58,500

The last insider sell of Aridis Pharmaceuticals's stock was made by Patzer Eric on Jun 15 2023, selling 12,000 shares at - per share (valued at -). The last insider buy of ARDS was made by Patzer Eric on Jun 28 2024, buying 714,286 shares at $0.07 per share (worth $50.00K).

Aridis Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20245--
Q3 20235--
Q2 2023126200.00%
Q4 202281800.00%
Q2 20222--
Q4 202161600.00%
Q3 20216--
Q2 20212--
Q1 20211--
Q4 2020-1-
Q2 20203--
Q1 202011100.00%
Q3 20195--
Q2 20191--
Q1 20192--
Q4 20185--
Q3 2018-17-
Q2 2018-1-
Q1 2018-2-
Q4 2017-2-

5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Aridis Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20242--
Q3 2023---
Q2 2023---
Q4 2022---
Q2 2022---
Q4 2021---
Q3 20216--
Q2 2021---
Q1 2021---
Q4 2020---
Q2 2020---
Q1 2020---
Q3 2019---
Q2 2019---
Q1 2019---
Q4 2018---
Q3 2018---
Q2 2018---
Q1 2018---
Q4 2017---

As of Q2 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Aridis Pharmaceuticals's stocks.

Aridis Pharmaceuticals Peer Ownership


TickerCompany
ZVSAZyVersa Therapeutics, Inc.
HOTHHoth Therapeutics, Inc.
RVPHReviva Pharmaceuticals Holdings, Inc.
ABVCABVC BioPharma, Inc.
ADTXAditxt, Inc.
REVBRevelation Biosciences, Inc.
RNAZTransCode Therapeutics, Inc.
AKTXAkari Therapeutics, Plc
SGTXSigilon Therapeutics, Inc.
DRMADermata Therapeutics, Inc.
VRAXVirax Biolabs Group Limited
KODKodiak Sciences Inc.
EYENEyenovia, Inc.
NRBONeuroBo Pharmaceuticals, Inc.
UNCYUnicycive Therapeutics, Inc.
ACSTAcasti Pharma Inc.
CGTXCognition Therapeutics, Inc.
ATXIAvenue Therapeutics, Inc.

ARDS Ownership FAQ


Aridis Pharmaceuticals is owned by institutional shareholders (0.00%), insiders (18.05%), and public (81.95%). The largest institutional shareholder of Aridis Pharmaceuticals is BARTLETT & CO. WEALTH MANAGEMENT LLC (0% of total shares) and the top mutual fund owner is Starboard Investment Trust (0.77% of total shares).

Aridis Pharmaceuticals's major institutional shareholders are BARTLETT & CO. WEALTH MANAGEMENT LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Dec 2023, there are 1 institutional shareholders of Aridis Pharmaceuticals.

BARTLETT & CO. WEALTH MANAGEMENT LLC owns 0 shares of Aridis Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).